Introduction: Salivary biomarkers have been extensively studied in relation to oral disease, such as periodontal disease, oral cancer, and dental caries, as well as systemic conditions including diabetes, cardiovascular diseases, and neurological disorders. Literature Review: A systematic literature review was conducted, analyzing recent advancements in salivary biomarker research. Databases such as PubMed, Scopus, and Web of Science were searched for relevant studies published in the last decade. The selection criteria included studies focusing on the identification, validation, and clinical application of salivary biomarkers in diagnosing oral and systemic diseases. Various detection techniques, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry, and biosensor technologies, were reviewed to assess their effectiveness in biomarker analysis. Specific biomarkers, such as inflammatory cytokines, oxidative stress markers, and microRNAs, have been identified as reliable indicators of disease progression. Current Trends and Future Perspectives: Advances in proteomics, genomics, and metabolomics have significantly enhanced the ability to analyze salivary biomarkers with high sensitivity and specificity. Despite the promising findings, challenges remain in standardizing sample collection, processing, and analysis to ensure reproducibility and clinical applicability. Conclusions: Future research should focus on developing point-of-care diagnostic tools and integrating artificial intelligence to improve the predictive accuracy of salivary biomarkers.

Anxiety and depression are highly prevalent mental health disorders often associated with dysregulation of neuroendocrine and immune systems, particularly the hypothalamic–pituitary–adrenal (HPA) axis and the sympathetic–adrenal–medullary (SAM) system. Recent research highlights the potential of salivary biomarkers to serve as non-invasive indicators for psychological distress. This narrative review synthesizes current evidence on key salivary biomarkers, cortisol, alpha-amylase (sAA), secretory immunoglobulin A (sIgA), chromogranin A (CgA), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), C-reactive protein (CRP), brain-derived neurotrophic factor (BDNF), and salivary microRNAs (miRNAs), in relation to anxiety, depression, and stress. A comprehensive literature search (2010–2025) was conducted using multiple databases and relevant MeSH terms. The review reveals consistent associations between these salivary analytes and stress-related disorders, reflecting changes in neuroendocrine activity, immune response, and neuroplasticity. Cortisol and sAA mirror acute stress reactivity, while cytokines and CRP indicate chronic inflammation. BDNF and miRNAs provide insight into neuroplastic dysfunction and gene regulation. Despite promising results, limitations such as variability in sampling methods and biomarker specificity remain. In conclusion, salivary biomarkers offer a promising avenue for early detection, monitoring, and personalization of treatment in mood and anxiety disorders. Conclusions: Cortisol and alpha-amylase serve as the principal markers of acute stress response, whereas cytokines such as IL-6 and TNF-α, together with CRP, indicate chronic inflammation associated with extended emotional distress.

Hyaluronic acid (HA), a naturally occurring glycosaminoglycan and major component of the extracellular matrix, has attracted increasing interest as a therapeutic adjunct in oral wound management due to its biological activity and biocompatibility. The search for the current narrative review literature was performed in the PubMed/MEDLINE, Scopus, and Web of Science databases for studies published up to December 2025. Eligible studies included experimental investigations, clinical trials, and relevant reviews assessing HA applications in oral mucosal or gingival wounds. Available clinical evidence suggests potential benefits of HA in reducing postoperative discomfort, accelerating re-epithelialization, and improving soft tissue healing following periodontal and surgical procedures. However, substantial heterogeneity exists regarding molecular weight, formulation, concentration, and application protocols, which limits direct comparison between studies and precludes definitive conclusions. Further well-designed, standardized clinical trials are required to clarify optimal formulations and confirm long-term therapeutic benefits.

Background: The interaction between prosthetic restorations and periodontal health is a critical factor for the long-term success of dental treatments. A biologically compatible prosthetic design supports periodontal stability, whereas neglecting periodontal principles can compromise treatment outcomes. This study aimed to validate a questionnaire designed to assess dentists’ perceptions regarding the influence of prosthetic restorations on the periodontium. Material and Methods: An observational cross-sectional study was conducted using a self-administered questionnaire distributed to licensed dentists across Romania. The questionnaire underwent expert review, pilot testing (n = 50), and statistical validation, including the Content Validity Index (CVI), Cronbach’s alpha for internal consistency, and Exploratory Factor Analysis (EFA) using Principal Component Analysis (PCA) with Varimax rotation. The final sample included 39 respondents. Data was analyzed using SPSS v26.0. Results: The questionnaire demonstrated excellent internal consistency (Cronbach’s alpha = 0.900; standardized alpha = 0.917). Most items had corrected item-total correlations > 0.40. EFA revealed eight coherent factors explaining 81.68% of total variance, with high communalities (0.549–0.966), strong Kaiser–Meyer–Olkin test (KMO) values, and significant Bartlett’s test values, confirming construct validity. Descriptive statistics showed predominantly positive attitudes among dentists regarding the periodontal considerations in prosthetic treatment. The highest-rated items emphasized oral hygiene, periodontal stability, and biological adaptation of restorations. Lower scores were associated with routine use of periodontal indices and recognition of failures due to insufficient evaluation. Conclusions: The validated instrument proved reliable and demonstrated strong psychometric properties in this exploratory validation, supporting its use in research and education. Romanian dentists demonstrated a favorable perception of the role of periodontal health in prosthetic success. This tool can inform curriculum development and interdisciplinary clinical protocols in prosthodontics and periodontology.

Polymerization shrinkage remains a primary cause of marginal failure in posterior composite restorations, contributing to interfacial gap formation and secondary caries development. Bioactive filler technologies represent a paradigm shift, offering simultaneous stress reduction and therapeutic ion release through engineered matrix–filler interactions. This narrative review synthesizes current evidence on how bioactive glass (including 45S5), amorphous calcium phosphate, and surface pre-reacted glass-ionomer fillers modulate polymerization shrinkage dynamics and mechanical performance in bulk-fill systems. These systems exhibit distinct mechanisms of bioactivity, with bioactive glass (45S5) promoting ion release and apatite formation, amorphous calcium phosphate (ACP) enabling rapid calcium phosphate ion delivery for remineralization, and surface pre-reacted glass-ionomer (S-PRG) fillers providing sustained multi-ion release with buffering and antibacterial potential. A comprehensive literature search was conducted in PubMed/MEDLINE, Scopus, and Web of Science for studies published up to June 2025, including experimental investigations and reviews assessing bioactive filler integration, with studies selected based on predefined inclusion and exclusion criteria focusing on relevance and reported outcomes. The available evidence indicates that optimized bioactive formulations reduce shrinkage stress by approximately 25–40%, decreasing from 35–40 MPa in conventional systems to 22–32 MPa in bioactive bulk-fill composites while maintaining flexural strength above 100 MPa and elastic modulus within clinically acceptable ranges (11–13 GPa). However, substantial heterogeneity in filler chemistry, loading protocols, and testing methodologies limits cross-study comparisons. This variability also reflects differences in testing conditions, material compositions, and evaluation protocols across studies.

Hydroxyapatite-based biomaterials are widely investigated for oral-tissue-healing applications; however, the available literature is heterogeneous in terms of material design, experimental models, and reported outcomes. This narrative review synthesizes peer-reviewed studies published between 2014 and 2024 that investigate hydroxyapatite-based biomaterials in the context of oral soft and hard tissue healing. The literature was identified through targeted searches of major scientific databases and selected based on relevance to material characteristics, biological response, and oral regenerative applications. The analysis reveals substantial heterogeneity in material formulation, experimental design, and outcome assessment, limiting direct comparison between studies and translational interpretation. While modified and nano-sized hydroxyapatite systems often demonstrate enhanced biological responses, supporting evidence is predominantly preclinical. Greater standardization of methodologies and outcome measures is required to strengthen clinical relevance.